相关实验视频
Updated: Jul 3, 2025

12:03
Viability Assays for Cells in Culture
Published on: January 20, 2014
46.3K
关于参与神经退行性疾病的非病毒性,非细菌性传染剂毒性的综述
Mohammad Taheri1, Ali Bahrami2, Kiana Kimiaei Asadi2
1Department of Medical Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Neurodegenerative disease management
|February 15, 2024
概括
感染和微生物代谢物与神经退行性疾病有关. 这次审查发现了将传染病与这些疾病联系在一起的证据,其中一些真菌和微藻类显示出对阿尔茨海默氏症和帕金森氏症的治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 传染性疾病 传染性疾病
- 微生物学 微生物学
背景情况:
- 像阿尔茨海默氏症和帕金森症这样的神经退行性疾病涉及神经元功能障碍.
- 新出现的证据表明,感染和微生物代谢物有助于神经退行.
- 了解这些联系对于开发新型治疗策略至关重要.
研究的目的:
- 系统地审查有关传染病原体及其代谢物在神经退行性疾病病理生理学中的作用的现有文献.
- 巩固关于神经退行性疾病中特定感染病原体存在的发现.
- 探索微生物衍生化合物的潜在治疗作用.
主要方法:
- 在PubMed,Scopus,Google Scholar和Web of Science中进行全面的文献搜索.
- 包括在神经退行性疾病中研究传染病原体及其代谢物的研究.
- 对报告的关联和观察到的影响进行分析.
主要成果:
- 已经确定了与神经退行性疾病相关的几个传染病原体.
- 特定的真菌和微藻类分离物在帕金森病和阿尔茨海默病模型中表现出有益作用.
- 微生物的代谢物显示在疾病病理生理学中起作用.
结论:
- 传染病原体及其代谢物是神经退行性疾病病理生理学的重要因素.
- 一些微生物化合物,特别是来自真菌和微藻,为治疗阿尔茨海默氏症和帕金森病提供了有希望的途径.
- 需要进一步的研究来阐明机制并开发有针对性的治疗方法.
相关概念视频
Parkinson's Disease: Overview
546
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
546
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Alzheimer's Disease: Treatment
189
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
189
Alzheimer's Disease: Overview
484
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
484

